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ABSTRACT
Human sperm-associated antigen 11 (SPAG11) is closely
related to beta-defensins in structure, expression, and function.
Like the beta-defensins, SPAG11 proteins are predominantly
expressed in the male reproductive tract, where their best-
known major roles are in innate host defense and reproduction.
Although several hypotheses have emerged to describe the
evolution of beta-defensin and SPAG11 multifunctionality, few
describe these multiple functions in terms of defensin interac-
tions with specific proteins. To gain insight into the protein
interaction potentials of SPAG11 and the signaling pathways
that SPAG11 may influence, we used a yeast two-hybrid
screening of a human testis-epididymis library. The results
reveal human SPAG11B isoform D (SPAG11B/D) interactions
with tryptase alpha/beta 1 (TPSAB1), tetraspanin 7 (TSPAN7),
and attractin (ATRN). These interactions were confirmed by
coimmunoprecipitation and glutathione S-transferase affinity
matrix binding. SPAG11B/D and the three interacting proteins
are expressed in the proximal epididymis, and all function in
immunity and fertility pathways. We analyzed the functional
consequences of SPAG11B/D interaction with TPSAB1 and
showed that SPAG11B/D is both a substrate and a potent
inhibitor of TPSAB1 activity. Furthermore, we show that (like
SPAG11B/D) TSPAN7 and ATRN are associated with spermato-
zoa.
attractin, beta-defensin, epididymis, gene regulation, male
reproductive tract, signal transduction, sperm, spermatozoa,
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INTRODUCTION
During evolution, an adjacent highly conserved inverted
duplicate of the defensin gene cluster that contains the human
sperm-associated antigen 11 (SPAG11) gene formed on
chromosome 8p23 [1, 2]. Thus, there are two SPAG11 genes,
designated SPAG11A and SPAG11B. Their exons are 97%–
100% identical. Alternative splicing generates mRNAs encod-
ing more than 20 SPAG11 protein isoforms, designated A
through W [3–5]. The C-terminal domain (G72–I133) of human
SPAG11B isoform D (designated SPAG11B/D), containing an
antibacterial cationic defensin-like six-cysteine array highly
similar to that of human beta-defensin 4 (DEFB4) (previously
known as human beta-defensin 2 [hBD2] [6]), places
SPAG11B/D in the beta-defensin protein family. SPAG11A/D
is distinguished from SPAG11B/D by a base change that
resulted in the substitution of a serine for the third cysteine in
the SPAG11A/D defensin signature motif. This mutation
would result in the loss of a disulfide bridge, altering the
protein tertiary structure. Thus, in this study we investigated
SPAG11B/D, which encodes the entire six-cysteine array. The
SPAG11B/D N-terminal 46-amino acid unstructured common
region (R26–Q71) also displays potent antibacterial activity [4,
6], despite its lack of recognized antibacterial motifs.
Most mammalian beta-defensin genes, including SPAG11,
are expressed predominantly in the male reproductive tract [2,
7–16]. Several defensins are associated with spermatozoa [7,
17–20] and are implicated in sperm maturation and function
[19–23]. Male tract expression and association with sperma-
tozoa are consistent with activities related to reproduction and
host defense [2, 11, 24, 25].
The localization of SPAG11B/D on human sperm head and
neck regions indicated that it might have specific functions
through association with specific receptors [18]. Beta-defensin
interactions with different receptors are the subject of several
recent reviews [26–29]. Human DEFB4 chemoattracts and
regulates dendritic cells through toll-like receptor 4 activation
and through binding the CCR6 receptor [30]. Human DEFB4
also chemoattracts, regulates gene expression, and affects
intracellular signaling in human neutrophils [26, 31, 32].
Recently, canine beta-defensin 103 was shown to bind the
receptor for melanocortin 1 [33], which controls pigmentation,
feeding behavior, and inflammation [32]. Based on this
accumulating evidence of cell regulation mediated by defen-
sin-receptor interactions, we hypothesized that SPAG11B/D-
protein associations could lead to modulation of signaling
pathways involved in host defense, reproduction, and other
unidentified functions.
To investigate this model, we used a yeast-protein
interaction screening method to identify SPAG11B/D interact-
ing proteins. Although we identified several interacting
partners, herein we describe human SPAG11B/D association
with three proteins, namely, tryptase alpha/beta 1 (TPSAB1)
[31], tetraspanin 7 (TSPAN7) [34], and attractin (ATRN) [35],
which are implicated in host defense and reproductive
functions. Our kinetic evidence shows that TPSAB1 is
competitively inhibited by SPAG11B/D, an action that could
affect tryptase activities in host defense and reproduction.
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Human Recombinant SPAG11 Protein Production
Human recombinant SPAG11B/D protein was expressed and purified as
described previously [18]. In short, Origami B (DE3) lac IQ cells (Novagen,
Madison, WI) were transformed with SPAG11B/D cDNA (GenBank accession
number AF168617) in pQE30 (Qiagen, Valencia, CA) according to the
manufacturer’s protocol. Fusion protein expression was induced, and proteins
were purified according to the manufacturer’s recommendations (Qiagen).
Pooled fractions were dialyzed and analyzed on 4%–12% NuPage gels
(Invitrogen, Carlsbad, CA) and stained with Coomassie blue G250.
Yeast Two-Hybrid Screening
SPAG11B/D bait plasmids were prepared by cloning the full-length mature
human SPAG11B/D (R26–I133) and, as controls, SPAG11B/G (R26–G108) and
the common region of SPAG11B/D (R26–Q71) [18, 36] into the EcoRI/SalI
sites of pBD-GAL4-Cam (Stratagene, La Jolla, CA). The human testis
MATCHMAKER cDNA library (Clontech, Palo Alto, CA) was analyzed by
PCR and was found to contain epididymis-specific sequences SPAG11B/C and
cystatin 11 (CST11 [a cysteine protease inhibitor]) (data not shown) and thus
would be expected to yield interacting factors originating from both testis and
epididymis. The screening was performed by cotransformation of the
SPAG11B/D bait plasmid and the human testis cDNA library into yeast
AH109. The positive cDNA clones were cotransformed back into AH109 yeast
cells with SPAG11B/D bait plasmids and the two control baits, SPAG11B/D
amino terminus and SPAG11B/G, to confirm the positive interaction with
SPAG11B/D and to exclude targets interacting with control bait proteins. Final
identification of the target DNA sequences was obtained by BLAST searching
the human genome (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Confirmation of Specificity of the Two-Hybrid Interaction
by Coimmunoprecipitation and Glutathione S-Transferase
Affinity Matrix Binding
The strength of the interactions was further demonstrated by coimmuno-
precipitation of recombinant proteins coexpressed in COS-7 cells by a method
previously described [37]. Full-length cDNAs for interacting partners were
obtained by PCR amplification using the following human clones as templates:
tryptase (American Type Culture Collection [Rockville, MD] [ATCC] MGC-
39869), TSPAN7 (ATCC MGC-26217), and ATRN secreted form (kindly
supplied by Dr. Jonathan Duke-Cohan, Department of Medical Oncology,
Dana-Farber Cancer Institute, Boston, MA). Briefly, COS-7 cells were
cotransfected using the diethylaminoethyl-dextran method [38, 39] with
pSG5-SPAG11B/D expression vector and FLAG-tagged partner vectors or
empty FLAG vector. FLAG antibody (Sigma-Aldrich, St. Louis, MO) was used
to immunoprecipitate FLAG-labeled proteins from cotransfected COS cell
lysates. Precipitated proteins were separated by PAGE and transferred to
nitrocellulose membranes, and the blots were incubated with the human
SPAG11B/D peptide antibody [18]. Immunoreactive bands were visualized by
chemiluminescence (Pierce Biotechnology, Inc., Rockford, IL).
Direct interaction of SPAG11B/D with partners was demonstrated in vitro
in the glutathione-sepharose affinity matrix assay as previously described [37].
Briefly, glutathione S-transferase (GST)-SPAG11B/D fusion protein and GST
alone were expressed in Escherichia coli. The concentrations of recombinant
proteins in extracts of these bacteria were determined by immunoblotting using
GST antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Full-length
cDNAs for the three partners in pSG5 were templates for the synthesis of [35S]-
labeled TPSAB1, TSPAN7, and ATRN using the TNT Quick Coupled
Transcription/Translation kit (Promega Corp., Madison, WI). Glutathione-
sepharose beads (Pharmacia Biotech, Piscataway, NJ) were loaded with equal
amounts of GST-SPAG11B/D or GST in PBS (150 mM NaCl and 10 mM
sodium phosphate [pH 7.5]) containing 1 mg/ml bovine serum albumin and
0.02% NP40. [35S]-labeled interacting partner was mixed with washed loaded
beads and incubated for 1 h at 48C and again washed with PBS buffer. Bound
proteins were released by boiling in SDS sample buffer and analyzed by PAGE
in 10% SDS gels. Input lanes contained 10% of the binding reaction mixtures.
The results shown are representative of three independent experiments. Gels
were dried and autoradiographed using BioMax mass spectrometry film
(Eastman Kodak Co., Rochester, NY).
Immunohistochemical Localization
Tissues for immunohistochemistry were fixed and paraffin embedded as
previously described [18]. For SPAG11B/D, sections were stained using rabbit
antiserum (1:5000) against a human C-terminal peptide [18]. For the control
staining, antibody was preincubated with this antigen peptide (10 lg/ml).
Tryptase antibody for epididymal caput staining (Fig. 1F) was mouse anti-
human mast cell tryptase IgG1 purified by protein G affinity chromatography
catalog number M2415–01 (1:500 for specific and 1:5000 for control) (United
States Biological, Swampscott, MA). For epididymal efferent duct staining
(Fig. 1G), tryptase antibody was catalog number 17039 (E-17) goat (1:500)
with blocking peptide (100 lg/ml) for control staining (Santa Cruz
Biotechnology, Inc.). Antibody to TSPAN7 (University of Texas Southwestern
Medical Center at Dallas) was murine polyclonal antibody A0859 (1:1000 for
specific and 1:10 000 for control). ATRN antibody (1:200) was catalog number
sc-9328 (C-19) affinity-purified goat polyclonal raised against a peptide
mapping near the C-terminal of human ATRN (Santa Cruz Biotechnology,
Inc.). The C-19 peptide (100 lg/ml) was the blocking agent in control stainings.
F2RL1 antibody was sc-8205 (C-17) (Santa Cruz Biotechnology, Inc.) at 1:500
for specific staining and at 1:2000 for control staining. The double peroxidase-
antiperoxidase method [40] was used for immunostaining SPAG11B/D. The
Vectastain Standard avidin-biotin-complex horseradish peroxidase kit (Vector
Laboratories Inc., Burlingame, CA) was used to demonstrate immunoreactive
TPSAB1, TSPAN7, ATRN, and F2RL1 using diaminobenzidine as chromo-
gen, resulting in a dark brown reaction product. Sections were counterstained
with toluidine blue. Photographs were taken with a SPOT Cooled Color digital
imaging system (Diagnostic Instruments, Inc., Sterling Heights, MI) attached to
a Nikon (Natick, MA) E600 microscope using the 403 objective.
Human spermatozoa were fixed and stained as previously described [5].
Surplus swim-up spermatozoa were obtained after approval by the University
of North Carolina at Chapel Hill Human Subjects Committee and with
informed consent and were provided by the Assisted Reproductive Technology
Clinic, University of North Carolina at Chapel Hill. Immunofluorescent
staining used the same primary antibodies as the tissue staining; for controls the
primary antibodies were omitted for tryptase and TSPAN, and for ATRN
antibody was preincubated with peptide (100 lg/ml). The tryptase antibody
was diluted 1:10, TSPAN7 antibody was diluted 1:100, and ATRN antibody
was diluted 1:50. After overnight incubation with primary antibody, sperm
slides were washed, blocked, and incubated with Alexa Fluor second antibodies
(1:2000) (Molecular Probes, Eugene, OR; and Invitrogen). Slides were washed
and mounted in ProLong antifade medium (Molecular Probes). Spermatozoon
images were taken using a Zeiss (Thornburg, NY) Axiophot microscope with a
Zeiss Axiocam digital camera using the 633 objective.
RT-PCR
A panel of excess surgical human tissues was obtained from the Lineberger
Comprehensive Cancer Center tissue bank, University of North Carolina at
Chapel Hill. Total RNA was extracted from these tissues using Trizol reagent
(Invitrogen). Total RNA was reverse transcribed using Stratascript (Stratagene)
according to the supplier’s instructions. Gene-specific intron-spanning primer
sequences were designed for SPAG11B forward 50-GCGGGATCCAGG
CAACGATTGC and reverse 5 0-GCGGGTACCCATACGGCAGATGG,
ATRN forward 50-ACAACAGCACCATGTATGTGTTCGG and reverse 50-
CAGTAGTACATGGGGTTATCCTTGG, TPSAB1 forward 5 0-ATG
GAAAACCACATTTGTGACGC and reverse 50-CCAAGTAGTAGGTGA
CACGG, TSPAN7 forward 50-GACACCTTCCTGAGGACTTACAC and
reverse 50-GATGAACCGGGACAGACAGC, and peptidylprolyl isomerase
A (PPIA) forward 50-CATGGTCAACCCCACCGTGTTCTTCG and reverse
50- GCAGGAACCCTTATAACCAAATCCTTTCTC. The PCR reactions were
carried out using 2 ll of the resultant cDNA according to the following
procedures: 948C for 1 min, followed by 23–38 cycles at 948C for 30 sec, 588C
for 30 sec, and 728C for 1 min, and a final round of extension for 5 min at 728C.
The number of cycles in the linear amplification range for each gene was
determined using human epididymal cDNA template transcribed from total
RNA isolated from human epididymis. Amplification of PPIA, which served as
an internal control in this semiquantitative analysis, was carried out in parallel
using similar conditions for 23 cycles. The PCR-amplified products were
analyzed by electrophoresis on 2% agarose gels. Gel-purified PCR products
were sequenced as described previously [24].
Immunoblotting
Human spermatozoa and seminal plasma obtained from the Assisted
Reproduction Clinic at University of North Carolina Memorial Hospital,
Chapel Hill, were prepared in lysis buffer (8 M urea), and protein lysates were
clarified by centrifugation at 14 000 rpm for 15 min at room temperature. The
protein content was determined by BioRad (Hercules, CA) protein assay.
Twenty micrograms of protein was separated in each lane in NuPAGE Bis-Tris
gels (4%–12%) (Invitrogen) and transferred to polyvinylidene fluoride
membrane (Invitrogen). This amount was equivalent to the protein extracted








from 9 million spermatozoa or the seminal plasma surrounding 0.15 million
spermatozoa. The membranes were blocked in 1% casein in Tris-buffered
saline (TBS) for 2 h, followed by incubation with primary antibody for
SPAG11B/D (1:1000) [18] or interacting partners for 1 h at room temperature.
Membranes were washed with TBS containing 0.05% Tween (TBST) and
incubated with horseradish peroxidase-conjugated anti-rabbit IgG (1:20 000)
for 1 h. Following washes in TBST, the bound antibodies were detected by an
Enhanced Chemiluminescence using the manufacturer’s protocol (Pierce).
Partner-specific primary antibodies used for immunoblots were the same as
those used for staining spermatozoa, except that the TSPAN7 antibody was
mouse monoclonal catalog number OP175 (Oncogene Research Products/
CalBiochem, San Diego, CA).
Mass Spectrometric Analysis
of Tryptase-SPAG11B/D Digestions
Recombinant human tryptase (10 ng) (Promega Corp.) (supplied in 10 mM
2-[4-morpholino]-ethane-sulfonic acid [MES], 10% glycerol, 200 mM NaCl,
and 0.5 mg/ml heparin [pH 6.1]) was incubated with 400 lg of recombinant
SPAG11B/D in PBS (pH 7.4)/0.1% Triton X-100 for 2 min. Tryptase-digested
products were directly analyzed by mass spectrometry using matrix-assisted
laser desorption ionization (MALDI). A MALDI-time of flight (MALDI-TOF)
was performed on the Bruker Reflex III mass spectrometer (Reflex Analytical,
Ridgewood, NJ), and MALDI-TOF/TOF was performed on the AB 4700
Voyager-Proteomics Discovery System (Applied Biosystems, Foster City, CA).
All protein and peptide mass spectrometry was performed at the University of
North Carolina Michael Hooker Specialized Cooperative Centers Program in
Reproduction and Infertility Research (SCCPIR) Proteomics Core Facility.
The peptide samples were first analyzed by nanospray on an ABI Q-Star
mass spectrometer (Applied Biosystems). The accurate molecular weights were
then compared with the theoretical digests of the substrate peptide, which were
calculated using the Waters/Micromass MassLynx software package (Waters
Corp., Milford, MA). For these analyses, the sample was dissolved in 50:50
methanol:water (1% formic acid), and the nanospray mass spectra were acquired
over the mass range of 500-2500 Da. The ABI Analyst software (Applied
Biosystems) was used to deconvolute the resulting electrospray mass spectra.
The higher (.3000 Da) molecular weight products were determined on a
Bruker Reflex III MALDI-TOF mass spectrometer (Bruker Daltonics, Billerica,
MA). A saturated solution of recrystallized a-cyano-4-hydroxycinnamic acid
(Aldrich, Milwaukee, WI) in 50:50 acetonitrile:high-performance liquid
chromatography-grade water (0.1% trifluoroacetic acid) was used as the
matrix, and spectra were acquired over two different mass ranges, namely,
mass-to-charge ratio (m/z) 600-6000 Da (reflectron mode) and m/z 600–30 000
Da (linear mode). Spectra were acquired over the mass range of 800-4000 Da
FIG. 1. SPAG11B/D interaction with tryp-
tase and expression in epididymis. A)
SPAG11B/D coimmunoprecipitated from
extracts of COS cells expressing recombi-
nant SPAG11B/D and FLAG-tagged TPSAB1
but not from control protein extracts (Con)
from COS cells cotransfected with
SPAG11B/D and the empty FLAG vector.
Input shown in lower panel. B) GST affinity
matrix binding assay. Lane Input: [35S]-
labeled TPSAB1; lane Con: control binding
to GST-glutathione beads; lane TPSAB1:
specific binding of TPSAB1 to GST-
SPAG11B/D bound to glutathione beads. C)
The RT-PCR total RNA was isolated from 1)
parotid, 2) thyroid, 3) breast, 4) lung, 5)
liver, 6) spleen, 7) kidney, 8) colon, 9)
adrenal, 10) ovary, 11) seminal vesicle, 12)
epididymal caput, 13) corpus, 14) cauda,
15) prostate, and 16) testis. D–F) Left panels:
specific epididymal immunostaining; right
panels: control staining. D) SPAG11B/D at
caput-efferent duct border. E) SPAG11B/D
in efferent duct. F) TPSAB1 in efferent duct;
larger arrows indicate mast cells, and
smaller arrows indicate expression in lumi-
nal compartments of principal cells. G)
TPSAB1 in efferent duct. H) F2RL1 in
efferent duct. Immunodetection is indicated
by the brown color. Sections were counter-
stained with toluidine blue. Photographs
were taken using the 403 objective. Bars ¼
100 lm (D) and 50 lm (E–H).








using an ABI 4700 TOF/TOF mass spectrometer (Applied Biosystems) and the
same MALDI matrix as that already described but with 40 mM ammonium
citrate instead of water. Tandem mass spectrometry spectra were also acquired
from 69 Da to the mass of the precursor ion 6 50 ppm to determine or confirm
the sequence of selected peptides. As already described, the MALDI-mass
spectrometry and tandem mass spectrometry spectra were compared with the
theoretical digest to assign peptide sequences to the observed peaks.
Enzyme Kinetics
All enzymatic assays were performed three to six times at room temperature
in triplicate in 96-well microtiter plates. The linear range of the assay was
determined using varying concentrations of the synthetic substrate with fixed
enzyme concentration and using varying enzyme concentrations with fixed
substrate concentration from 0 to 2 min (data not shown). In standard incubations,
10 ng of recombinant human skin beta-tryptase (EC 3.4.21.59) supplied in 10 mM
MES, 10% glycerol, 200 mM NaCl, and 0.5 mg/ml heparin (pH 6.1) (Promega
Corp.) was diluted in PBS and added to the wells in a total volume of 100 ll of
PBS (pH 7.4)/0.1% Triton X-100. Reactions contained different concentrations of
recombinant peptides and the chromogenic substrate S-2288 (H-D-Ile-L-Pro-L-
ArgpNA) (Chromogenix, Orangeburg, NY). The leaving group of this substrate is
paranitroaniline, which has an absorbance maximum at 385 nm. The change in
the rate of absorbance was measured at the longer wavelength (405 nm) to
minimize background. Data were collected using a UV/MAX Kinetic Microplate
reader (Molecular Devices, Sunnyvale, CA) interfaced with a computer. Initial
analysis was performed using SoftMAX Pro software (version 2.6.1; Molecular
Devices). Maximum initial velocity (Vmax), concentration of substrate that leads
to half-maximal velocity (Km), inhibition constant (Ki), and all statistical values
(by two-tailed Student t-test) were calculated for the enzyme substrate reaction
and the inhibition by recombinant human SPAG11B/D full-length protein, N-
terminal peptide and C-terminal peptide, and CST11 using Prism software
(GraphPad Software, Inc., San Diego, CA).
RESULTS
Expression, Localization, and Interaction of SPAG11B/D
and TPSAB1
We identified several interacting partners of SPAG11B/D
using a yeast two-hybrid strategy that has not been used
previously (to our knowledge) to identify defensin protein
partners. Initially, we chose to study three interacting proteins
that have been implicated in host defense and reproductive
functions. Using the full-length SPAG11B/D (R26–I133) as bait,
we discovered that the C-terminal two thirds of TPSAB1
(L101–H268) is an interacting protein. This region of TPSAB1
includes the active site D121 and S224 residues that are essential
for peptide cleavage activity. TPSAB1 is involved in both host
defense and reproductive functions [41–44]. In this screening,
TPSAB1 failed to bind the N-terminal SPAG11 common
region (R26–Q71) and SPAG11B/G (R26–G108) as determined
by yeast colony beta-galactosidase assays (data not shown).
This result suggested that in yeast TPSAB1 interacted
specifically with the C-terminal region of SPAG11B/D (G72–
I133), which contains the defensin-like motif that is implicated
in immunity and fertility [19].
The association between SPAG11B/D and TPSAB1 was
confirmed by coimmunoprecipitation from COS cells express-
ing SPAG11B/D and FLAG-tagged full-length TPSAB1 but
not from cells transfected with SPAG11B/D and the empty
FLAG vector (Fig. 1A). Further confirmation of SPAG11B/D
and TPSAB1 interaction was obtained by in vitro GST affinity
matrix binding assays (Fig. 1B). Full-length [35S] tryptase
binding to the GST-SPAG11B/D beads was much greater than
that to control GST beads. Binding of a negative control
protein, lipocalin 6 (LCN6), to GST-SPAG11B/D beads was
weak and not greater than binding to GST beads (data not
shown).
Initially regarded as epididymis specific [45], SPAG11
mRNAs were later detected in other male reproductive organs
[46]. To determine SPAG11B/D expression in a broad range of
tissues, we evaluated relative steady-state mRNA levels by RT-
PCR. Abundant expression of SPAG11B/D mRNA was present
in epididymis (Fig. 1C). Lower levels of expression were
detected in thyroid (19% of expression in epididymis), lungs
(22%), seminal vesicle (31%), prostate (14%), and testis (11%).
TPSAB1 mRNA was widely distributed, including in the caput
epididymis (data not shown), as expected because of the
presence of mast cells. SPAG11B/D protein is abundant in the
principal cells of the caput epididymis (Fig. 1D) and is
expressed in the epithelium of efferent ducts (Fig. 1E).
TPSAB1 is known to be present in seminal plasma, although
its origins are unclear [43]. We wished to determine the
location of its expression in the epididymis to identify where it
might interact with SPAG11B/D. TPSAB1 was abundant in
caput epididymis mast cells (Fig. 1F) (wide arrows). It was also
present within caput epithelial cells and on their luminal
surfaces (narrow arrows) (Fig. 1F), as well as in the epithelium
of efferent ducts (Fig. 1G). These epithelial cells may be
among the sources of the tryptase found in seminal plasma. A
major mediator of tryptase action, coagulation factor II
receptor-like 1 (F2RL1), previously known as proteinase-
activated receptor 2 (PAR2) [43], is expressed in efferent duct
epithelial cells, especially on the microvilli (Fig. 1H).
Numerous secreted epididymal proteins are reported to be
present on human ejaculate spermatozoa and carried into the
female tract, where they are implicated in egg fertilization [47].
In contrast, TPSAB1 was not detected on spermatozoa (Fig.
2A) or in sperm extracts (Fig. 2C). However, TPSAB1 (Fig.
2C) and SPAG11B/D (Fig. 2D) were detected in seminal
plasma, suggesting that this may be a site of interaction.
SPAG11B/D in human sperm extracts was detected primarily
as an 8-kDa species and a 20-kDa aggregate. In seminal
plasma, immunodetection of SPAG11B/D revealed a 12-kDa
species, the predicted mass of the full-length protein, and an 8-
kDa species in equal amounts (Fig. 2D). The 8-kDa form has
FIG. 2. TPSAB1 and SPAG11B/D on human spermatozoa and in seminal
plasma. TPSAB1-specific (A) and control (B) green immunofluorescent
staining of spermatozoa show little difference. Photographs were taken
using the 633 objective. Bar ¼ 30 lm. C) Immunoblot showing that
TPSAB1 was not detected in sperm extracts (Sp) but was detected in
seminal plasma (Se). D) Immunoblot detection of SPAG11B/D in sperm
extracts (Sp) and seminal plasma (Se). kDa indicates positions of
molecular mass markers.








the mass of the prohormone convertase cleavage product (D61–
I133) reported previously [43]. SPAG11B/D in seminal plasma
may originate largely in the epididymis but also in the testis,
prostate, and seminal vesicles, where we detected the mRNA as
shown in Figure 1A and as previously reported [46].
SPAG11B/D as a Substrate of TPSAB1
Cationic defensins are likely natural substrates for TPSAB1,
which cleaves on the carboxyl side of basic residues. To
investigate the possible enzymatic action of human TPSAB1
on full-length SPAG11B/D and C-terminal peptide, TPSAB1
was incubated with different concentrations of recombinant
SPAG11B/D for increasing times. The 2-min incubation with
full-length recombinant SPAG11B/D (14 kDa with His tag)
yielded several distinct species, including an 8-kDa peptide, a
4-kDa peptide, and other products (Fig. 3A [b]). A prolonged
incubation (20 min) resulted in smaller-sized fragments with
concomitant loss of the full-length protein (Fig. 3A [c]). The
initial SPAG11B/D cleavage products suggest the presence of
preferential cleavage sites. Additional cleavage products of the
C-terminal peptide were detected (Fig. 3B [e]) when digested
without the N-terminal 46 residues, suggesting a protective
effect of the N-terminal region. DEFB118 is similarly cleaved
by TPSAB1 (Fig. 3C [f and g]). LCN6, a control protein, was
not cleaved by TPSAB1, although it contains several K and R
residues (Fig. 3D [h and i]). To further analyze these results,
the TPSAB1-digested products were sequenced by mass
spectrometry. Mass spectrometry revealed that TPSAB1 did
indeed cleave full-length SPAG11B/D at the same site as
prohormone convertase R60 [48, 49], as well as other arginine
residues in the N-terminal region and one arginine in the C-
terminal peptide (Fig. 3F). Preferential cleavage of the N-
terminal region may reflect the more open accessible structure
of this domain compared with the compact disulfide bond-
constrained structure of the C-terminal region.
Enzyme Kinetics
To determine whether SPAG11B/D affects TPSAB1
enzymatic activity, the enzyme was incubated with increasing
concentrations of SPAG11B/D (0.008–0.33 mM) for up to 1.33
min in the presence of synthetic substrate S-2288. Full-length
SPAG11B/D (Fig. 4) and the N-terminal region (Table 1)
strongly inhibited TPSAB1 activity, and the carboxyl terminus
of SPAG11B/D had no effect (Table 1). This result is
consistent with our evidence that the N-terminal is cleaved
by TPSAB1 more readily than the C-terminal. Moreover, if
FIG. 3. TPSAB1 cleaves SPAG11B/D in
preferential cleavage sites. A) Full-length
SPAG11B/D untreated (a) and after incuba-
tion with TPSAB1 for 2 min (b) and for 20
min (c). B) SPAG11B/D C-terminal peptide
untreated (d) and incubated with TPSAB1
for 20 min (e). C) DEFB118 untreated (f) and
incubated with TPSAB1 for 20 min (g). D)
LCN6 recombinant protein untreated (h)
and incubated with TPSAB1 for 20 min (i).
E) Sample MALDI-TOF/TOF results showing
relative amounts of different TPSAB1
cleavage products of SPAG11B/D. F)
SPAG11B/D amino acid sequence. N-ter-
minal peptide (R26–Q71) is black. C-termi-
nal peptide (G72–I133) is grey. Cleavage sites
(arrows) most often detected by mass
spectrometry are located on the carboxyl
side of bold amino acids.








TPSAB1 binds to the carboxyl region in these experiments, this
does not appear to interfere with active site access or function.
An epididymal-specific recombinant control protein, CST11,
did not affect tryptase cleavage of S-2288 (Table 1).
Nonlinear regression analysis (Table 1) showed that, with
the addition of 0.33 lM full-length SPAG11B/D, the apparent
mean 6 SEM Km for TPSAB1 cleavage of S-2288 increased
to 0.42 6 0.07 mM from 0.10 6 0.01 mM (P , 0.001; n¼ 6).
The addition of 0.33 lM amino terminal region resulted in an
increase in the apparent Km for S-2288 to a mean 6 SEM of
1.25 6 0.35 mM (P , 0.0002; n ¼ 6). The Vmax remained
constant (mean 6 SEM, 46.3 6 5.2 milli optical density/min)
throughout these experiments. The addition of increasing
concentrations of SPAG11B/D decreased the affinity of
TPSAB1 for the S-2288 by a mean 6 SEM of 2.65 6 0.10
fold (P , 0.001; n ¼ 4). These results indicate that the N-
terminal region and full-length SPAG11B/D are competitive
inhibitors of TPSAB1. Furthermore, the calculated inhibition
constants for the full-length and N-terminal regions (36 nM and
21 nM, respectively) were not significantly different by
unpaired Student t-test (P ¼ 0.0813; n ¼ 3). These inhibition
constants are similar to the previously determined Ki of 24 nM
for lactoferrin, a potent noncompetitive inhibitor of TPSAB1
[50]. In our experiments, DEFB118 also decreased the affinity
of TPSAB1 for the S-2288 (data not shown). Taken together,
the data from electrophoretic and mass spectrometric analyses
of cleavage fragments and the enzyme kinetics show that
SPAG11B/D acts as a substrate for TPSAB1 and as a potent
competitive inhibitor of TPSAB1 activity.
Other Interacting Partners of SPAG11B/D
In addition to TPSAB1, two other proteins not previously
known to interact with SPAG11B/D were identified in this
study. These target proteins are full-length TSPAN7
(M1V249) and ATRN isoform 3 C-terminal region
(G737Q1198) containing the C-lectin domains. TSPAN7 and
ATRN are involved in host defense and reproductive activities
[35, 51–53].
The association between SPAG11B/D and TSPAN7 was
confirmed by coimmunoprecipitation (Fig. 5A) and GST affinity
matrix binding (Fig. 5B). Unlike SPAG11B/D mRNA, which
was expressed primarily in the male reproductive tract (Fig. 1C),
TSPAN7 was detected in all tissues analyzed (Fig. 5C). Similar
to SPAG11B/D protein, TSPAN7 was expressed in the proximal
epididymal epithelia (Fig. 5D), where it was detected in caput
principal cells and was abundant on the microvilli, also known
as sterocilia. Immunofluorescence studies detected TSPAN7 on
the spermatozoa head, neck, and midpiece (Fig. 5E). In addition
to cellular localization, TSPAN7 was detected in ejaculate sperm
extracts and in seminal plasma (Fig. 5F).
The association between SPAG11B/D and ATRN was
confirmed by coimmunoprecipitation (Fig. 6A) and GST
affinity matrix binding (Fig. 6B). ATRN expression was
detected in all tissues analyzed (Fig. 6C). ATRN was expressed
inside the principal cells of efferent ducts and was concentrated
on the luminal surfaces (Fig. 6D). ATRN was localized on the
spermatozoa head, neck, and midpiece, and low levels were
found on the tail principal piece (Fig. 6E). ATRN was also
detected in ejaculate sperm extracts and in seminal plasma (Fig.
6F).
FIG. 4. Kinetics of SPAG11B/D inhibition of TPSAB1 activity. Michaelis-
Menten plot shows that increasing amounts of SPAG11B/D decrease the
velocity of the substrate cleavage reaction. The TPSAB1 reactions
proceeded in the presence of the following concentrations of recombinant
SPAG11B/D: black square, 0.0 lM; triangle, 0.008 lM; black diamond,
0.04 lM; and circle, 0.33 lM. Experiments were performed three to six
times independently, the data shown are representative of at least three
independent experiments, and each data point was collected in triplicate.
Data are represented as the mean 6 SE. mOD, milli optical density.
TABLE 1. Calculations of enzyme kinetics.*
Peptide sequence SPAG11B/D (lM) Km 6 SEM (mM) t-Test P valuea,b
Vmax 6 SEM
(milli optical density/min) t-Test P valuea,b
Control 0.00 0.17 6 0.01 45.20 6 2.97
R26-I133 0.008 0.17 6 0.03 NS 42.27 6 5.08 NS
R26-I133 0.04 0.23 6 0.01 0.0046 45.56 6 4.16 NS
R26-I133 0.08 0.35 6 0.04 0.001c 39.36 6 6.57 NS
R26-I133 0.33 0.42 6 0.07 0.001c 46.30 6 5.22 NS
R26-Q71 0.008 0.20 6 0.02 NS 36.18 6 6.39 NS
R26-Q71 0.04 0.50 6 0.17 0.0043c 34.94 6 0.63 NS
R26-Q71 0.08 1.02 6 0.40 0.0023c 42.71 6 6.23 NS
R26-Q71 0.33 1.25 6 0.35 0.0002c 43.46 6 5.99 NS
G72-I133 0.008–0.33 0.21 6 0.01 0.0091 46.37 6 1.42 NS
CST11 0.008–0.33 0.20 6 0.01 NS 49.77 6 1.24 NS
* One-way ANOVA was performed using the Km or Vmax from each of three to six independent experiments.
a P values were obtained employing a two-tailed unpaired t-test (confidence level 99%) comparing each treatment with the control TPSAB1 cleavage of S-
2288 in the absence of SPAG11B/D.
b NS, Not significant.
c Statistically significant P value; the variances were not different by the F-test.









The results of this study provide evidence that SPAG11B/D
has the potential for multifunctionality through interactions
with TPSAB1, TSPAN7, and ATRN, which could extend the
actions of SPAG11B/D to the regulation of epididymis and
spermatozoa [18] in addition to its antibacterial actions in host
defense [6]. As components of diverse major signaling
cascades, these binding partners affect both reproductive and
host defense systems [19, 31, 34, 35, 51–53].
Evidence indicates that SPAG11B/D is available to inhibit
tryptase in epididymal fluid and seminal plasma. In epididymal
fluid, the tryptase inhibitory N-terminal peptide of SPAG11B/
D was found by sequencing isolated peptides, and the
inhibitory full-length SPAG11B/D was detected by immuno-
blotting [48]. Immunodetection revealed the N-terminal
peptide [43] and full-length SPAG11B/D (Fig. 2D) in seminal
plasma. One action of tryptase is to cleave the F2RL1 receptor
on spermatozoa, resulting in reduced motility [43]. A
hypothetical function of SPAG11B/D could be to modulate
TPSAB1-dependent suppression of sperm motility.
The conserved R60 [1, 5] site of cleavage by TPSAB1 and
prohormone convertase suggests an important function.
Cleavage at R60 was suggested to activate SPAG11B/D [48,
49] similar to the tightly regulated cleavage activation of alpha-
defensin human defensin 5 [54] and other defensins [55].
Because the uncleaved full-length SPAG11B/D also exhibits
potent antibacterial action [6], the physiological role of
cleavage may have an as-yet undefined function [4, 6]. The
presence of the cleaved SPAG11B/D in sperm extracts (Fig.
2D) may be an indication of a role in mature sperm function.
SPAG11B/D may provide protection in testis by suppress-
ing the activity of TPSAB1 released from mast cells. A
tryptase-dependent F2RL1 activation mechanism was suggest-
ed to underlie the fibrotic thickening of seminiferous tubule
walls that causes male infertility [41]. Activated tryptase-
producing mast cells are increased in testes of subfertile and
infertile men [56], and a drug that prevents tryptase release
improved sperm counts [57]. Further studies are needed to
determine the role of SPAG11B/D in controlling inflammatory
fibrosis.
The possibility that defensin family members other than
SPAG11B/D and DEFB118 could interact with tryptase family
members should be investigated not only in male reproductive
tissues but also in other epithelial environments, including
lungs. Several defensins are abundant [58, 59] and SPAG11B/
D is expressed [60] in epithelial cells of airway passages, where
tryptase activation of F2RL1 is involved in allergic inflamma-
tion, including asthma [61]. As inhibitors of tryptase activity,
SPAG11B/D and perhaps other defensins could potentially
modulate these inflammatory responses in a manner similar to
tryptase inhibitors that are developed for clinical application
[62].
TSPAN7 is a recently discovered member of a family of
four-transmembrane domain molecular complex organizers
that modulate the activities of associated molecules [63, 64].
Tetraspanins are implicated in many cellular functions,
including adhesion, migration, signal transduction, and
sperm-egg fusion [51]. Tetraspanins are ubiquitously present
FIG. 5. SPAG11B/D interaction with
TSPAN7. A) SPAG11B/D coimmunopreci-
pitated from extracts of COS cells express-
ing recombinant SPAG11B/D and FLAG-
tagged TSPAN7 but not from control protein
extracts (Con) of COS cells. B) GST affinity
matrix binding assay. Lane Input: [35S]-
labeled TSPAN7; lane Con: control binding
to GST-glutathione beads; lane D: specific
binding of TSPAN7 to GST-SPAG11B/D. C)
The RT-PCR for TSPAN7 shows expression
in all tissues analyzed. Lanes 1–16: same as
in Figure 1C. D) Left panel: expression of
TSPAN7 protein in caput epididymis; right
panel: control staining. Bar ¼ 50 lm. E) Left
panel: TSPAN7 on human spermatozoa;
right panel: control staining. Bar ¼ 30 lm.
F) Immunoblot detection of TSPAN7 in
sperm extracts (Sp) and seminal plasma (Se).








in all cell and tissue types in species ranging from
Caenorhabditis elegans to humans, and they have important
roles in membrane organization [65]. Two other tetraspanins,
CD9 and CD81, function in membrane fusion events, including
sperm-oocyte fusion [66–69]. The interaction of SPAG11B/D
and TSPAN7 suggests that SPAG11B/D has functional effects
in both sperm and epididymis epithelial cell membranes.
ATRN, another facilitator of membrane-spanning protein
interaction, is also widely expressed (Fig. 6) and [70]. The
large extracellular domain contains CUB, Kelch, C-type lectin,
dipeptidylpeptidase, and endothelial growth factor-like do-
mains that mediate cell adhesion and other macromolecular
interactions [70]. A hypothetical mechanism by which ATRN
and SPAG11B/D could collaborate in host defense might
involve binding pathogens through the ATRN C-type lectin
domain, as C-type lectins recognize pathogen surface carbo-
hydrate structures and trigger their killing [53].
ATRN binds agouti signaling protein (ASIP) and chemo-
kines in addition to SPAG11B/D, all of which are small basic
disulfide bond-stabilized proteins, perhaps the defining features
of ATRN ligands. Evidence indicates that ATRN acts as a
coreceptor for ASIP, an inhibitory ligand of melanocortin
receptors [71]. Several beta-defensins are ligands of the
melanocortin receptors in competition with ASIP [33].
Although the rapid proliferation and divergence of defensins
and melanocortin receptors occurred during the same evolu-
tionary period (450–500 million years ago) [2, 24, 25, 72],
recruitment of beta-defensins as modulators of melanocortin
receptor signaling appears to be a recent event in mammalian
evolution [72]. These lines of evidence taken together suggest
that SPAG11-defensin interactions with melanocortin receptors
mediated through ATRN are components of a novel signaling
paradigm, and future studies will describe their roles in the
male reproductive tract.
In summary, we conclude that the identification of
SPAG11B/D interacting proteins represents a step toward the
discovery of novel pathways of SPAG11B/D action. These
possibly include roles in sperm maturation and host defense,
two fundamental activities of the epididymis. The male
reproductive tract function of SPAG11B/D as an inhibitor of
TPSAB1 activity opens the possibility of a role for SPAG11B/
D in sperm motility in seminal plasma. SPAG11B/D
partnership with TSPAN7 and ATRN and their plausible roles
in immunity and fertility remain to be investigated.
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